Seelos Therapeutics, Inc. (SEEL) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Seelos Therapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
50/100
Moderate
Valuation Metrics
P/E Ratio
-22.85
Weak
WeakModerateStrong
P/B Ratio
-25.83
Weak
WeakModerateStrong
Earnings Yield
-4.38%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
113.05%
Strong
WeakModerateStrong
Operating Margin
-1838.36%
Weak
WeakModerateStrong
Net Profit Margin
-1719.56%
Weak
WeakModerateStrong
Growth Indicators
Revenue Growth
N/A%
Net Income Growth
50.25%
Strong
WeakModerateStrong
EPS Growth
64.01%
Strong
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
0.14
Weak
WeakModerateStrong
Quick Ratio
0.14
Weak
WeakModerateStrong
Asset Turnover
0.41x
Weak
WeakModerateStrong
Inventory Turnover
0.00x
Weak
WeakModerateStrong